<p>Despite great improvements in mortality for children under 5, sepsis remains a leading cause of death in young children. The highest incidence and mortality were seen in newborns, with the biggest impact seen in low- and middle-income countries in sub-Saharan Africa and Asia. This episode will highlight how the availability of guidelines, diagnostics, and therapeutics can make a difference in the smallest of patients. Content warning: this episode contains discussions of infant loss.</p> <p><strong>Guests:</strong></p> <p><strong>Kamala Thiagarajan</strong> - Freelance journalist, Global health and environmental sciences</p> <p><strong>Seamus O’Brien</strong> - Director of Research and Development, Global Antibiotic Research and Development Program</p> <p><strong>Phoebe Williams</strong> - Pediatrician, Infectious Disease Physician, Faculty of Medicine,&nbsp; University of Sydney</p> <p><strong>Materials Mentioned in this Episode</strong></p> <p><a href="https://www.bbc.com/future/article/20220927-neonatal-sepsis-the-new-threat-posed-by-superbugs#:~:text=Now%20a%20new%20enemy%20is,the%20face%20of%20raging%20infections.">Neonatal sepsis: the new threat posed by superbugs</a>, Kamala Thiagarajan, BBC</p> <p><a href="https://pubmed.ncbi.nlm.nih.gov/36466207/">Antibiotics needed to treat multidrug-resistant infections in neonates</a>, Phoebe Williams, …, Seamus O’Brien et al., Bulletin of the World Health Organization</p>

Podden och tillhörande omslagsbild på den här sidan tillhör CIDRAP. Innehållet i podden är skapat av CIDRAP och inte av, eller tillsammans med, Poddtoppen.